Bone-targeted, nonpeptide inhibitors of the Src SH2 domain: Structure-based design and structure-activity relationships

被引：0

作者：

Bohacek, R ^{[1
]}

Weigele, M ^{[1
]}

Jacobsen, V ^{[1
]}

Macek, K ^{[1
]}

Luke, G ^{[1
]}

Sundaramoorthi, R ^{[1
]}

Metcalf, C ^{[1
]}

Shakespeare, W ^{[1
]}

Yang, M ^{[1
]}

Wang, YH ^{[1
]}

Kawahata, N ^{[1
]}

Takeuchi, C ^{[1
]}

Haraldson, C ^{[1
]}

Varkhedkar, V ^{[1
]}

Johnson, D ^{[1
]}

Hatada, M ^{[1
]}

Lu, XD ^{[1
]}

Narula, S ^{[1
]}

Eyermann, C ^{[1
]}

Violette, S ^{[1
]}

Bartlett, C ^{[1
]}

Guan, W ^{[1
]}

Smith, J ^{[1
]}

Adams, S ^{[1
]}

Lynch, B ^{[1
]}

MacNeil, I ^{[1
]}

van Schravendijk, MR ^{[1
]}

Stebbins, K ^{[1
]}

Wood, S ^{[1
]}

Li, P ^{[1
]}

Yuan, R ^{[1
]}

Dalgarno, D ^{[1
]}

Cerasoli, F ^{[1
]}

Sawyer, T ^{[1
]}

机构：

[1] ARIAD Pharmaceut Inc, Cambridge, MA 02139 USA

来源：

PEPTIDES FOR THE NEW MILLENNIUM | 2000年

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：558 / 560

页数：3

共 50 条

[1] Structure-based design of novel bicyclic nonpeptide inhibitors for the Src SH2 domain
Shakespeare, WC
Bohacek, RS
Azimioara, MD
Macek, KJ
Luke, GP
Dalgarno, DC
Hatada, MH
Lu, XD
Violette, SM
Bartlett, C
Sawyer, TK
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (21) : 3815 - 3819
[2] Structure-activity relationships of a novel class of Src SH2 inhibitors
Buchanan, JL
Vu, CB
Merry, TJ
Corpuz, EG
Pradeepan, SG
Mani, UN
Yang, M
Plake, HR
Varkhedkar, VM
Lynch, BA
MacNeil, IA
Loiacono, KA
Tiong, CL
Holt, DA
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (16) : 2359 - 2364
[3] Structure-based de novo design and discovery of nonpeptide antagonists of the pp60src (Src) SH2 domain
Para, KS
Lunney, EA
Plummer, MS
Stankovic, CJ
Shahripour, A
Holland, D
Rubin, JR
Humblet
Fergus, J
Marks, J
Hubbell, S
Herrera, R
Saltiel, AR
Sawyer, TK
PEPTIDES: FRONTIERS OF PEPTIDES SCIENCE, 1999, : 173 - 175
[4] Structure-based design of novel nonpeptide inhibitors of the Src SH2 domain: Phosphotyrosine mimetics exploiting multifunctional group replacement chemistry
Sundaramoorthi, R
Kawahata, N
Yang, MG
Shakespeare, WC
Metcalf, CA
Wang, YH
Merry, T
Eyermann, CJ
Bohacek, RS
Narula, S
Dalgarno, DC
Sawyer, TK
BIOPOLYMERS, 2003, 71 (06) : 717 - 729
[5] Design, synthesis, and cocrystal structure of a nonpeptide Src SH2 domain ligand
Plummer, MS
Holland, DR
Shahripour, A
Lunney, EA
Fergus, JH
Marks, JS
McConnell, P
Mueller, WT
Sawyer, TK
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (23) : 3719 - 3725
[6] Structure-based design and synthesis of a novel class of Src SH2 inhibitors
Buchanan, JL
Bohacek, RS
Luke, GP
Hatada, M
Lu, XD
Dalgarno, DC
Narula, SS
Yuan, R
Holt, DA
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (16) : 2353 - 2358
[7] Structure-based design of a novel series of nonpeptide ligands that bind to the pp60src SH2 domain
Lunney, EA
Para, KS
Rubin, JR
Humblet, C
Fergus, JH
Marks, JS
Sawyer, TK
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (51) : 12471 - 12476
[8] Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption
Violette, SM
Guan, W
Bartlett, C
Smith, JA
Bardelay, C
Antoine, E
Rickles, RJ
Mandine, E
Van Schravendijk, MR
Adams, SE
Lynch, BA
Shakespeare, WC
Yang, M
Jacobsen, VA
Takeuchi, CS
Macek, KJ
Bohacek, RS
Dalgarno, DC
Weigele, M
Lesuisse, D
Sawyer, TK
Baron, R
BONE, 2001, 28 (01) : 54 - 64
[9] X-ray structure of citrate bound to Src SH2 leads to a high-affinity, bone-targeted Src SH2 inhibitor
Bohacek, RS
Dalgarno, DC
Hatada, M
Jacobsen, VA
Lynch, BA
Macek, KJ
Merry, T
Metcalf, CA
Narula, SS
Sawyer, TK
Shakespeare, WC
Violette, SM
Weigele, M
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (05) : 660 - 663
[10] Structure-activity relationships of small phosphopeptides, inhibitors of Grb2 SH2 domain, and their prodrugs
Liu, WQ
Vidal, M
Olszowy, C
Million, E
Lenoir, C
Dhôtel, H
Garbay, C
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (05) : 1223 - 1233

← 1 2 3 4 5 →